Skip to main content

Table 2 Hemodynamic, pulmonary function and CPET parameters

From: Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis

Parameter

N

Group 1 dcSSc, n = 88

Group 2 lcSSc, n = 122

p-value (group 1 vs. 2)

Echocardiography available (n)

192

80 (90.9%)

112 (91.8%)

0.819

TR detected (n)

169

65 (80.3%)

104 (89.7%)

0.063

Estimated RVsys (mmHg)

159

31 (25; 38)

32 (25; 45)

0.498

Right heart catheter available (n)

139

49 (55.7%)

90 (73.8%)

0.006

RAPmean (mmHg)

135

5 (2; 7)

5 (3; 7)

0.653

PAPmean (mmHg)

136

23 (16; 33)

21 (15; 30)

0.161

PAPmean ≥ 25 mmHg

136

20 (42.6%)

32 (36.0%)

0.451

PAWP (mmHg)

136

9 (5; 13)

7 (6; 10)

0.059

PVR (Wood units)

134

2.68 (1.62; 5.34)

2.17 (1.49; 4.94)

0.587

Cardiac output (L∙min−1)

123

5.17 (4.40; 5.93)

4.94 (4.22; 5.88)

0.251

PAH (n)

134

13 (27.7%)

25 (28.7%)

0.895

TLC (% predicted)

205

93.8 (79.0; 107.0)

103.6 (90.9; 115.9)

0.026

VC (% predicted)

206

85.2 (75.8; 102.0)

100.5 (83.3; 109.0)

0.005

FVC (% predicted)

201

87 (75; 105)

97 (84; 110)

0.037

Proportion of patients with FVC ≤70% predicted

201

17 (20.0%)

10 (8.6%)

0.019

FEV1 (% predicted)

206

90 (77; 104)

95 (84; 107)

0.002

FEV1/FVC (%)

204

83 (78; 90)

79 (74; 86)

0.571

RV (% predicted)

204

104 (84; 124)

114 (95; 138)

0.468

RV/TLC (% predicted)

194

105,1 (92,6;122,2)

99,1 (87,1;111,7)

0.110

DLCO (% predicted)

190

60 (43; 77)

68 (45; 84)

0.616

Proportion of patients with DLCO ≤60% predicted

190

40 (50.6%)

42 (37.8%)

0.079

KCO (% predicted)

191

74.0 (56.6; 89.2)

71.8 (59.8; 86.3)

0.616

FVC (% pred.)/‌DLCO (% pred.)

185

1.48 (1.22; 1.94)

1.42 (1.22; 1.96)

0.719

6-MWD (m)

96

447 (372; 525)

423 (370; 478)

0.798

Maximum power (Watts)

209

84 (68; 100)

84 (68; 116)

0.723

Maximum power (% predicted)

209

87 (62; 117)

97 (75; 118)

0.180

VO2@AT in % of peakVO2 predicted

197

41.5 (31.8; 55.8)

41.0 (35.3; 47.1)

0.726

peakVO2 (mL∙min−1)

210

1171 (947; 1416)

1180 (899; 1476)

0.780

peakVO2 (% of predicted)

210

72.2 (58.4; 84.6)

75.2 (58.3; 90.0)

0.263

peakVO2/peakHR (L)

207

9.1 (7.2; 11.0)

9.0 (6.9; 10.8)

0.953

VE/VCO2-slope

200

31.6 (27.0; 40.0)

33.6 (28.0; 42.0)

0.117

VE/VCO2@rest

208

37 (32; 45)

38 (32; 43)

0.726

VE/VCO2@ AT

206

32 (29; 40)

34 (29; 42)

0.121

petCO2@rest

205

30.8 (27.5; 34.0)

30.8 (26.5; 34.0)

0.953

petCO2@AT

203

33.8 (29.8; 38.0)

33.0 (28.0; 37.9)

0.291

VE/MVV (%)

210

54.1 (43.5; 68.1)

55.2 (44.8; 63.4)

0.780

Proportion of VE/MVV > 80% (n)

210

9 (10.2%)

11 (9.0%)

0.768

  1. Data are presented as median (IQR) or n (%)
  2. 6-MWD walking distance in 6 min, CPET Cardiopulmonary exercise testing, DLCO Diffusion capacity of carbon monoxide, FEV1 Forced expiratory volume in 1 second, FVC Forced vital capacity, IQR Interquartile range, KCO Krogh factor (DLCO per alveolar volume), lcSSc limited cutaneous manifestation, PAH Pulmonary arterial hypertension, PAPmean mean pulmonary arterial pressure (by right heart catheter); RVsys Systolic pulmonary arterial pressure (by echocardiography), PAWP Pulmonary artery wedge pressure, peakVO2 peak oxygen uptake, petCO2 End tidal pressure of carbon dioxide, petCO2@AT End tidal pressure of carbon dioxide at anaerobic threshold, PVR Pulmonary vascular resistance, RAPmean mean right atrial pressure, RV Residual volume, TLC Total lung capacity, TR Tricuspid regurgitation, VC Vital capacity, VE/MVV Ratio of ventilation to maximum voluntary ventilation, VE/VCO2@AT Ratio of ventilation to carbon dioxide output at anaerobic threshold, VE/VCO2@rest Ratio of ventilation to carbon dioxide output at rest, VE/VCO2-slope Slope of the relation between ventilation and carbon dioxide output, VO2@AT Oxygen uptake at anaerobic threshold, VO2/HR Ratio of oxygen uptake to heart rate